Analyst Viewpoint
Significant increase in obese population across the globe is a prominent factor that is fostering plantar fasciitis treatment market development. Treatment for plantar fasciitis, an inflammation of the fibrous tissue along the bottom of the foot that connects the heel bone to toes, ranges from icing to heel pain surgery.
Rise in patient preference for hospitalization as compared to OTC treatment is also boosting the plantar fasciitis treatment industry value.
Companies operating in the global plantar fasciitis treatment market are devising technologically advanced products for plantar fasciitis for sportspersons, as athletes are highly prone to plantar fasciitis.
Key manufacturers of plantar fasciitis treatment products are following the latest plantar fasciitis treatment industry trends and offering customized products such as bespoke orthotic insoles as per personal clinical specifications to increase their industry share.
Plantar fasciitis is a common condition in which the plantar fascia, a thick fibrous ligament that supports the arch of the foot and connects the heel bone to the toe, becomes strained and inflamed, causing discomfort and heel pain.
Inflammation or damage to plantar fascia results in plantar fasciitis. Obese people and sportspersons are at greater risk of plantar fasciitis. As per a National Center for health Statistics (NCHS) report, one million people are likely to contract plantar fasciitis every year.
Orthotic insoles, shockwave therapy, and anti-inflammatory drugs are various options available to reduce pain caused due to planar fasciitis.Types of plantar fasciitis treatment include stretching and physical therapy, icing and medication, rest, activity modification, and orthotics, shockwave therapy, steroid injections, and gastrocnemius recession.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Rise in adoption of sedentary lifestyle, especially after the onset of the COVID-19 pandemic, is one of the key factors that has led to an increase in prevalence of obesity across the globe.
The obese population is more prone to ankle and joint inflammation, which may cause plantar fasciitis. Thus, rise in obese population worldwide is creating lucrative plantar fasciitis treatment market opportunities for companies operating in the sector.
According to OECD data published in 2022, obesity and other weight-related issues are widespread across the globe. These disorders are more prevalent in the U.S. due to excessive consumption of fast food, especially among the younger population, in the country.
As per the WHO, over 1 billion people across the world are obese. Healthcare personnel state that if the body mass index (BMI) is 30 or higher, the risk of contracting plantar fasciitis is six times higher.
People suffering from plantar fasciitis are increasingly opting for hospitalization, as symptoms related to the disorder such as inflammation and pain can be closely monitored by the healthcare personnel and subsequent course of action can be decided upon with immediate effect.
Painkillers such as steroids or NSAIDs are often administered to patients during the course of the treatment for plantar fasciitis. Side-effects of these medications can be better addressed through continuous monitoring during hospitalization.
Surgery is recommended if chronic heel pain continues even after adoption of remedies such as orthotic arch supports, splints, taping of foot, strengthening and stretching exercises, anti-inflammatory medications, massage, platelet-rich plasma injections, radiofrequency ablation, and extracorporeal shock wave therapy.
Decisions regarding plantar fasciitis surgery can be taken promptly during the course of hospitalization.Thus, increase in preference for hospitalization among people suffering from plantar fasciitis across the globe is one of the primary plantar fasciitis treatment market drivers.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
North America dominated the global plantar fasciitis treatment landscape in 2022. The region is expected to maintain its leading share during the forecast period.
The plantar fasciitis treatment market forecast appears promising in North America owing to the surge in incidence of obesity and availability of strong healthcare infrastructure in the U.S. and Canada.According to the latest plantar fasciitis treatment market analysis, Europe is projected to record steady industry progress in the near future.
As per NICE, 7% of the older and 4% of the general population in the U.K. suffers from plantar fasciitis. It further mentions that 8% to 10% of regular runners are afflicted with plantar fasciitis, which needs professional treatment.
As per the latest plantar fasciitis treatment market insights, companies operating in the global plantar fasciopathy treatment landscape are engaging in new product launches to cater to the growing population of individuals afflicted with plantar fasciitis. For instance, Ottobock has introduced the Malleo Immobil Night Splint that stretches the foot to facilitate nighttime healing.
Key players are investing substantially in research and development activities to introduce products that use a combination of extracorporeal shock therapy and local vibration for effective treatment of chronic plantar fasciitis.
Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc are some of the leading players operating in the global landscape.
The plantar fasciitis treatment market report highlights parameters such as company overview, business strategies, financial overview, product portfolio, and business segments of these companies.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 778.3 Mn |
| Market Forecast (Value) in 2031 | US$ 1.1 Bn |
| Growth Rate (CAGR) | 4.3% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Mn/Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 778.3 Mn in 2022
It is projected to grow at a CAGR of 4.3% from 2023 to 2031
Rise in obese population worldwide and growth in patient preference for hospitalization for treatment
The hospitals segment accounted for the largest share in 2022
North America was the dominant region in 2022
Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Plantar Fasciitis Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Medication Therapy
6.3.1.1. Oral
6.3.1.2. Parenteral
6.3.2. Shockwave Therapy
6.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
6.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
6.3.3. Surgery
6.3.4. Orthotics
6.3.5. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Plantar Fasciitis Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Type, 2017–2031
9.3.1. Medication Therapy
9.3.1.1. Oral
9.3.1.2. Parenteral
9.3.2. Shockwave Therapy
9.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
9.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
9.3.3. Surgery
9.3.4. Orthotics
9.3.5. Others
9.4. Market Value Forecast, by End-user, 2017–2031
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Market Value Forecast, by Country, 2017–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Type
9.6.2. By End-user
9.6.3. By Country
10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2017–2031
10.3.1. Medication Therapy
10.3.1.1. Oral
10.3.1.2. Parenteral
10.3.2. Shockwave Therapy
10.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
10.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
10.3.3. Surgery
10.3.4. Orthotics
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2017–2031
11.3.1. Medication Therapy
11.3.1.1. Oral
11.3.1.2. Parenteral
11.3.2. Shockwave Therapy
11.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
11.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
11.3.3. Surgery
11.3.4. Orthotics
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2017–2031
12.3.1. Medication Therapy
12.3.1.1. Oral
12.3.1.2. Parenteral
12.3.2. Shockwave Therapy
12.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
12.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
12.3.3. Surgery
12.3.4. Orthotics
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2017–2031
13.3.1. Medication Therapy
13.3.1.1. Oral
13.3.1.2. Parenteral
13.3.2. Shockwave Therapy
13.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
13.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
13.3.3. Surgery
13.3.4. Orthotics
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Hanger, Inc.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Bayer Group (Dr. Scholl’s)
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. A. Algeo Limited
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Bauerfeind AG
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Superfeet Worldwide, Inc.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Pfizer, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Sanofi
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. GlaxoSmithKline plc
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
List of Tables
Table 01: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 05: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 08: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 14: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 17: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 18: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Plantar Fasciitis Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by Type, 2022
Figure 03: Global Plantar Fasciitis Treatment Market Value Share, by Type, 2022
Figure 04: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by End-user, 2022
Figure 05: Global Plantar Fasciitis Treatment Market Value Share, by End-user, 2022
Figure 06: Global Plantar Fasciitis Treatment Market Value Share, by Region, 2022
Figure 07: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, 2023–2031
Figure 08: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031
Figure 09: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031
Figure 10: Global Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 11: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 12: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Region, 2022–2031
Figure 13: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Region, 2023–2031
Figure 14: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 15: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Country, 2022–2031
Figure 17: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031
Figure 18: North America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 19: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031
Figure 20: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 21: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 22: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 23: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 24: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031
Figure 25: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 26: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031
Figure 27: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 28: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 29: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 30: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 31: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031
Figure 32: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031
Figure 34: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 35: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 36: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 38: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031
Figure 39: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 40: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031
Figure 41: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Figure 42: Middle East & Africa Plantar Fasciitis Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 43: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 44: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 45: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031
Figure 46: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031
Figure 47: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031
Figure 48: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Plantar Fasciitis Treatment Market
*86 figures and 60 tables includes